Pharma Mar (MEX:PHM1N) Inventories, Work In Process: MXN0 Mil (As of Mar. 2026)


MEX:PHM1N Pharma Mar SA MEX:PHM1N
86 GF Score
Price MXN1,608.38
GF Value MXN1,937.69
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Inventories, Work In Process?

Pharma Mar MEX:PHM1N 86 Inventories, Work In Process is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:PHM1N with a GF Score™ of 86/100 and a GF Value™ of MXN1,937.69. The stock has 3 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Pharma Mar's work in process for the quarter that ended in Mar. 2026 was MXN0 Mil.


Pharma Mar Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Inventories, Work In Process Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 214.30 518.23 678.62 1,047.39 1,009.46

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,002.83 0.00 1,009.46 0.00
MEX:PHM1N
86GF Score
Pharma Mar SA MEX:PHM1N
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of MXN0 Mil mean?
Pharma Mar (MEX:PHM1N) has a Inventories, Work In Process of MXN0 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Pharma Mar and its competitors.
Is Pharma Mar's Inventories, Work In Process too high?
Pharma Mar's current Inventories, Work In Process is MXN0 Mil. Overall, Pharma Mar has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Inventories, Work In Process compare to VRTX and REGN?
Pharma Mar's Inventories, Work In Process of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Pharma Mar and its competitors. Pharma Mar's current Inventories, Work In Process is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Pharma Mar (MEX:PHM1N) has a current Inventories, Work In Process of MXN0 Mil. The stock's GF Value™ is MXN1,937.69, compared to a current price of MXN1,608.38 — trading 17% below its estimated fair value. The current Inventories, Work In Process is MXN0 Mil. Pharma Mar's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Pharma Mar (MEX:PHM1N), the current Inventories, Work In Process is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (MEX:PHM1N) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of MXN1,608.38 is trading 17% below its estimated GF Value™ of MXN1,937.69.

Key valuation signals for MEX:PHM1N:

  • Inventories, Work In Process: MXN0 Mil
  • GF Value™: MXN1,937.69 vs. price of MXN1,608.38 (17% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the MEX:PHM1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
86GF Score

Get the complete analysis for MEX:PHM1N

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,608.38
Price
MXN1,937.69
GF Value